Cellfe, Inc.
Alameda, CA Doing business as R&D Cellfe Inc.
- UEI
- M34JNT47EKK3
- CAGE
- 80SL2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1000 Atlantic Ave #104, Alameda, CA 94501, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Accelerated, scalable same-day microfluidic sequential gene editing for allogeneic cell therapy - project summary… | National Institute of General Medical Sciences | $314,000 | |
| Topic 397 - microfluidic transfection platform for rapid manufacturing of mrna car lymphocyte products. | National Cancer Institute | $358,930 | |
| Microfluidic platform for gene delivery into the t-cells | National Heart Lung and Blood Institute | $284,735 | |
| Efficient and scalable microfluidic gene delivery to hematopoietic stem cells to treat blood diseases - abstract the two… | National Heart Lung and Blood Institute | $2,517,688 | |
| Efficient and scalable microfluidic gene delivery to hematopoietic stem cells to treat blood diseases | National Heart Lung and Blood Institute | $223,810 |
About Cellfe, Inc.
Cellfe Inc. is a corporate entity registered in SAM.gov to receive federal contract and grant awards. Cellfe Inc. provides research and development services related to biomedical engineering and cell therapy manufacturing to federal agencies, primarily the National Institutes of Health.
Cellfe Inc. has received one prime SBIR Phase I federal contract from the National Cancer Institute for $358,930 to conduct research and development of a microfluidic transfection platform for rapid manufacturing of mRNA CAR lymphocyte products. This contract was awarded through a total small business set-aside under the SBIR program.
Cellfe Inc. has received three prime federal grants from the National Heart, Lung and Blood Institute. Two project grants worth $2,741,498 total were awarded to develop an efficient and scalable microfluidic gene delivery platform for genetic modification of hematopoietic stem cells to treat blood diseases. A third project grant worth $284,735 was awarded to develop a microfluidic platform for gene delivery into T-cells.
Quick answers
What is Cellfe, Inc.'s UEI?
Cellfe, Inc.'s Unique Entity ID (UEI) in SAM.gov is M34JNT47EKK3.
What is Cellfe, Inc.'s CAGE code?
Cellfe, Inc.'s CAGE code is 80SL2.
What is Cellfe, Inc.'s primary NAICS code?
Cellfe, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Cellfe, Inc. located?
Cellfe, Inc.'s physical address in SAM.gov is 1000 Atlantic Ave #104, Alameda, CA 94501, USA.
Is Cellfe, Inc. registered in SAM.gov?
Yes. Cellfe, Inc.'s SAM.gov registration is active through March 25, 2027.
What is Cellfe, Inc.'s most recent federal award?
Cellfe, Inc.'s most recent federal grant award is Accelerated, scalable same-day microfluidic sequential gene editing for allogeneic cell therapy - project summary… (R43GM161199), from National Institute of General Medical Sciences, on September 1, 2025.
On GovTribe
See Cellfe, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors